Search

everythinglearnresearchcommunity

for

Search:↓

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

The document covers various male health issues, their causes, treatments, and related conditions.

Androgens can both increase body hair and cause scalp hair loss.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.